News & Events
Lianhe Aigen CPHI Milan 2024 Exhibition Review

Lianhe Aigen CPHI Milan 2024 Exhibition Review

Oct. 11, 2024

Lianhe Aigen Pharma Co., Ltd. welcomed partners and experts of pharmaceutical industry from all over the world. Through comprehensive and multi-dimensional exchanges, Lianhe Aigen showcased one-stop CRDMO service capabilities for innovative drug solutions, as well as its Corporate brand image.

Lianhe Aigen’s First Quality Month Event Grandly Launched, Starting a New Journey of Quality Improvement

Lianhe Aigen’s First Quality Month Event Grandly Launched, Starting a New Journey of Quality Improvement

Sep. 04, 2024

Lianhe Aigen’s First Quality Month Event Grandly Launched, Starting a New Journey of Quality Improvement

Lianhe Aigen Receives EcoVadis Silver Medal for Sustainability for the First Time: Embarking on a New Journey Towards Green Development

Lianhe Aigen Receives EcoVadis Silver Medal for Sustainability for the First Time: Embarking on a New Journey Towards Green Development

Aug. 01, 2024

Lianhe Aigen Receives EcoVadis Silver Medal for Sustainability for the First Time: Embarking on a New Journey Towards Green Development

Lianhe Aigen CPHI Shanghai 2024 Exhibition Review

Lianhe Aigen CPHI Shanghai 2024 Exhibition Review

Jun. 22, 2024

Business and Technical teams from Lianhe Aigen participated in the exhibition, engaging in enthusiastic communication and exchange with partners, pharmaceutical industry experts, and entrepreneurs. Discussions with both new and existing clients focused on cooperation and development. The exhibition showcased Lianhe Aigen's one-stop CRDMO service ca

Lianhe Aigen passed the FDA audit inspection

Lianhe Aigen passed the FDA audit inspection

May. 08, 2024

Lianhe Aigen Pharma Co., Ltd. (formerly known as Lianhe Chemical Technology (Taizhou) Co., LTD.) is located at No. 3 Donghai 8th Avenue, Toumengang New District, Linhai, Taizhou, Zhejiang, which is mainly customizes and produces pharmaceutical intermediates and API for customers.

The second-level production safety standardization review passed smoothly

The second-level production safety standardization review passed smoothly

May. 01, 2024

November 7~8, 2023, Zhejiang Provincial Institute of Emergency Management Science and other 5 review experts visited our company for secondary safety production standardization on-site review. Lianhe Aigen Pharma Co., Ltd. (formerly known as Lianhe Chemical Technology (Taizhou) Co., LTD.) successfully passed the secondary safety production standard

What Can We Help You?

We provide customers with one-stop CRDMO services covering the entire lifecycle of drugs.

Introduction

We use cookies on our website to better understand how you use our website. For more information about how we use cookies, please visit our Terms of Use and Legal Notices and Privacy Statement and Cookies Policy. By continuing to use this website without changing your settings, you will be deemed to have consented to our use of cookies.